Compare Berkshire Hathaway Inc Class B (BRK.B) vs Davita Inc (DVA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Berkshire Hathaway Inc Class B vs Davita Inc — how do they compare? Berkshire Hathaway Inc Class B trades at $516.26, while Davita Inc trades at $179.02 (market cap $11.72B). The key difference: Berkshire Hathaway Inc Class B is trading nearer its 52-week high, Davita Inc nearer its low. Which is the better fit depends on your goals.
| BRK.B | DVA | |
|---|---|---|
Sector | Financials | Health |
52-Week High | $529.65 | $240.96 |
52-Week Low | $465.39 | $103.87 |
Market Cap | — | $11.72B |
Enterprise Value | — | $24.44B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
BRK.B trades at $529.65, up 1.73% with strong technical momentum indicated by bullish moving averages and ADX readings. Analyst consensus is positive with 57% buy ratings. The stock is near its pivot point of $530, with support at $522 and resistance at $536. Recent financial data is unavailable in the provided snapshot.
The outlook is cautiously optimistic given technical strength and analyst support, but reliance on broader market trends and Berkshire Hathaway's diverse portfolio performance remains key. Risks include market volatility and economic shifts affecting its holdings.
DaVita (DVA) trades at $183.77, up 1.72% today, with a mixed technical picture showing bearish moving averages but bullish oscillators. The company reported strong Q2 2026 earnings of $4.02 per share, beating estimates, driven by volume growth. Revenue reached $13.64 billion in 2025, with a net income margin of 6.05%. Analyst consensus is a Buy with a $232.25 price target, though technical signals are bearish overall.
The outlook for DVA is cautiously optimistic, supported by earnings beats and volume growth, but risks include reimbursement pressure and high debt levels. The stock offers potential upside to the consensus target, yet investors face headwinds from margin compression and technical bearishness.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Berkshire Hathaway Inc Class B
Berkshire Hathaway is a holding company with diverse subsidiaries, primarily in insurance through Geico and its reinsurance groups. It reinvests profits into various industries, owning Burlington Northern Santa Fe (railroad), Berkshire Hathaway Energy, and major manufacturing, service, and retail businesses like Precision Castparts and Lubrizol. The company operates in a highly decentralized manner.
Read more on BRK.B →About Davita Inc
DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,100 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives approximately 69% of U.S. sales at government (primarily Medicare) reimbursement rates, with the remaining 31% coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.
Read more on DVA →
